Literature DB >> 19133982

Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis.

Irene Riz, Teresa S Hawley, Helen Johnston, Robert G Hawley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19133982      PMCID： PMC2657812          DOI： 10.1111/j.1365-2141.2008.07556.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy.

Authors:  Vahid Asnafi; Kheira Beldjord; Marta Libura; Patrick Villarese; Corrine Millien; Paola Ballerini; Emilienne Kuhlein; Marina Lafage-Pochitaloff; Eric Delabesse; Olivier Bernard; Elizabeth Macintyre
Journal:  Blood       Date:  2004-03-30       Impact factor: 22.113

2.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

3.  TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.

Authors:  Bronwyn M Owens; Teresa S Hawley; Lisa M Spain; Kristi A Kerkel; Robert G Hawley
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

4.  Transition from EML1-ABL1 to NUP214-ABL1 positivity in a patient with acute T-lymphoblastic leukemia.

Authors:  K De Keersmaecker; I Lahortiga; C Graux; P Marynen; J Maertens; J Cools; P Vandenberghe
Journal:  Leukemia       Date:  2006-10-05       Impact factor: 11.528

5.  Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia.

Authors:  Idoya Lahortiga; Kim De Keersmaecker; Pieter Van Vlierberghe; Carlos Graux; Barbara Cauwelier; Frederic Lambert; Nicole Mentens; H Berna Beverloo; Rob Pieters; Frank Speleman; Maria D Odero; Marijke Bauters; Guy Froyen; Peter Marynen; Peter Vandenberghe; Iwona Wlodarska; Jules P P Meijerink; Jan Cools
Journal:  Nat Genet       Date:  2007-04-15       Impact factor: 38.330

6.  Transforming function of the HOX11/TCL3 homeobox gene.

Authors:  R G Hawley; A Z Fong; M D Reis; N Zhang; M Lu; T S Hawley
Journal:  Cancer Res       Date:  1997-01-15       Impact factor: 12.701

7.  G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia.

Authors:  Irene Riz; Robert G Hawley
Journal:  Oncogene       Date:  2005-08-25       Impact factor: 9.867

Review 8.  Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia.

Authors:  Pieter Van Vlierberghe; Rob Pieters; H Berna Beverloo; Jules P P Meijerink
Journal:  Br J Haematol       Date:  2008-08-07       Impact factor: 6.998

9.  A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups.

Authors:  Sarina Sulong; Anthony V Moorman; Julie A E Irving; Jonathan C Strefford; Zoe J Konn; Marian C Case; Lynne Minto; Kerry E Barber; Helen Parker; Sarah L Wright; Adam R M Stewart; Simon Bailey; Nick P Bown; Andrew G Hall; Christine J Harrison
Journal:  Blood       Date:  2008-10-06       Impact factor: 22.113

10.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.

Authors:  Adolfo A Ferrando; Donna S Neuberg; Jane Staunton; Mignon L Loh; Christine Huard; Susana C Raimondi; Fred G Behm; Ching Hon Pui; James R Downing; D Gary Gilliland; Eric S Lander; Todd R Golub; A Thomas Look
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743
  10 in total
  9 in total

1.  Apoptotic role of IKK in T-ALL therapeutic response.

Authors:  Irene Riz; Lynnsey A Zweier-Renn; Ian Toma; Teresa S Hawley; Robert G Hawley
Journal:  Mol Cancer Res       Date:  2011-07-05       Impact factor: 5.852

2.  Lentiviral fluorescent protein expression vectors for biotinylation proteomics.

Authors:  Irene Riz; Teresa S Hawley; Robert G Hawley
Journal:  Methods Mol Biol       Date:  2011

3.  Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1.

Authors:  Teresa S Hawley; Irene Riz; Wenjing Yang; Yoshiyuki Wakabayashi; Louis Depalma; Young-Tae Chang; Weiqun Peng; Jun Zhu; Robert G Hawley
Journal:  Am J Hematol       Date:  2013-03-08       Impact factor: 10.047

4.  Hematopoietic immortalizing function of the NKL-subclass homeobox gene TLX1.

Authors:  Lynnsey A Zweier-Renn; Teresa S Hawley; Sandra Burkett; Ali Ramezani; Irene Riz; Rima L Adler; Dennis D Hickstein; Robert G Hawley
Journal:  Genes Chromosomes Cancer       Date:  2010-02       Impact factor: 5.006

5.  The DN2 Myeloid-T (DN2mt) Progenitor is a Target Cell for Leukemic Transformation by the TLX1 Oncogene.

Authors:  Lynnsey A Zweier-Renn; Irene Riz; Teresa S Hawley; Robert G Hawley
Journal:  J Bone Marrow Res       Date:  2013-02-20

6.  Transcriptional activation by TLX1/HOX11 involves Gro/TLE corepressors.

Authors:  Irene Riz; Hyo Jung Lee; Kristin K Baxter; Reza Behnam; Teresa S Hawley; Robert G Hawley
Journal:  Biochem Biophys Res Commun       Date:  2009-01-23       Impact factor: 3.575

7.  Transcription factor TLX1 controls retinoic acid signaling to ensure spleen development.

Authors:  Elisa Lenti; Diego Farinello; Kazunari K Yokoyama; Dmitry Penkov; Laura Castagnaro; Giovanni Lavorgna; Kenly Wuputra; Lisa L Sandell; Naomi E Butler Tjaden; Francesca Bernassola; Nicoletta Caridi; Anna De Antoni; Michael Wagner; Katja Kozinc; Karen Niederreither; Francesco Blasi; Diego Pasini; Gregor Majdic; Giovanni Tonon; Paul A Trainor; Andrea Brendolan
Journal:  J Clin Invest       Date:  2016-05-23       Impact factor: 14.808

8.  TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells.

Authors:  Irene Riz; Teresa S Hawley; Truong V Luu; Norman H Lee; Robert G Hawley
Journal:  Mol Cancer       Date:  2010-07-09       Impact factor: 27.401

9.  Transient responses to NOTCH and TLX1/HOX11 inhibition in T-cell acute lymphoblastic leukemia/lymphoma.

Authors:  Lesley A Rakowski; Erica A Lehotzky; Mark Y Chiang
Journal:  PLoS One       Date:  2011-02-04       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.